Relapse of atypical hemolytic uremic syndrome triggered by COVID-19: a lesson for the clinical nephrologist

J Nephrol. 2023 Jun;36(5):1439-1442. doi: 10.1007/s40620-023-01595-y. Epub 2023 Mar 6.

¹ Department of Kidney Disease and Hypertension, Osaka General Medical Center, 3-1-56 Bandai-Higashi, Sumiyoshi-Ku, Osaka, 558-8558, Japan. [email protected].
² Department of Emergency Medicine, Osaka General Medical Center, Osaka, Japan.
³ Department of Kidney Disease and Hypertension, Osaka General Medical Center, 3-1-56 Bandai-Higashi, Sumiyoshi-Ku, Osaka, 558-8558, Japan.
⁴ Department of Nephrology, Nagoya University Graduate School of Medicine, Nagoya, Japan.

^# Contributed equally.

No abstract available

Keywords: Atypical hemolytic uremic syndrome; C3 gene variant; COVID-19; Coagulopathy; Complement activation; Thrombotic microangiopathy.

MeSH terms